Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(27%)
Results Posted
33%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
1
9%
Ph not_applicable
10
91%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Recruiting3
Terminated1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (9.1%)
N/A10 (90.9%)

Trials by Status

completed655%
terminated19%
enrolling_by_invitation19%
recruiting327%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11